We are live on ! Find out more
BFG

Bleakley Financial Group Portfolio holdings

AUM $6.39B
1-Year Est. Return 26.33%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+26.33%
3 Year Est. Return
+77.54%
5 Year Est. Return
10 Year Est. Return
AUM
$3.94B
AUM Growth
+$822M
Cap. Flow
+$523M
Cap. Flow %
13.27%
Top 10 Hldgs %
28.56%
Holding
591
New
86
Increased
351
Reduced
127
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 14.38%
2 Financials 6.17%
3 Healthcare 4.94%
4 Communication Services 4.46%
5 Consumer Discretionary 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOC icon
126
Northrop Grumman
NOC
$76B
$6.29M 0.16%
+12,575
New +$6.18M
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$122B
$6.2M 0.16%
13,931
+2,609
+23% +$1.2M
MU icon
128
Micron Technology
MU
$988B
$6.05M 0.15%
49,070
+3,833
+8% +$358K
IWS icon
129
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$5.99M 0.15%
45,364
-1,051
-2% -$132K
CGGR icon
130
Capital Group Growth ETF
CGGR
$23.7B
$5.93M 0.15%
145,947
+1,977
+1% +$72.1K
SAP icon
131
SAP
SAP
$209B
$5.83M 0.15%
19,156
-570
-3% -$163K
SPGI icon
132
S&P Global
SPGI
$122B
$5.81M 0.15%
11,025
+821
+8% +$410K
QCOM icon
133
Qualcomm
QCOM
$160B
$5.77M 0.15%
36,205
+1,642
+5% +$242K
SNY icon
134
Sanofi
SNY
$103B
$5.69M 0.14%
117,680
+3,890
+3% +$199K
TMO icon
135
Thermo Fisher Scientific
TMO
$214B
$5.65M 0.14%
13,925
-540
-4% -$226K
XCEM icon
136
Columbia EM Core ex-China ETF
XCEM
$1.88B
$5.56M 0.14%
162,735
+11,914
+8% +$372K
TAK icon
137
Takeda Pharmaceutical
TAK
$55.1B
$5.56M 0.14%
359,366
+32,794
+10% +$485K
DHR icon
138
Danaher
DHR
$138B
$5.52M 0.14%
27,938
+7,461
+36% +$1.45M
MRK icon
139
Merck
MRK
$321B
$5.52M 0.14%
69,715
-3,206
-4% -$255K
ACN icon
140
Accenture
ACN
$99.9B
$5.47M 0.14%
18,313
-96
-0.5% -$29.2K
KKR icon
141
KKR & Co
KKR
$90.7B
$5.44M 0.14%
40,918
+2,928
+8% +$343K
CGDG icon
142
Capital Group Dividend Growers ETF
CGDG
$5.45B
$5.32M 0.14%
158,235
+120,989
+325% +$3.84M
ROL icon
143
Rollins
ROL
$18.5B
$5.31M 0.13%
94,077
+714
+0.8% +$40.1K
NFG icon
144
National Fuel Gas
NFG
$7.84B
$5.29M 0.13%
62,496
+1,239
+2% +$100K
SYK icon
145
Stryker
SYK
$133B
$5.26M 0.13%
13,292
+633
+5% +$237K
PEG icon
146
Public Service Enterprise Group
PEG
$38.6B
$5.23M 0.13%
62,163
+1,438
+2% +$116K
AZN icon
147
AstraZeneca
AZN
$266B
$5.16M 0.13%
36,906
+2,025
+6% +$284K
DGT icon
148
State Street SPDR Global Dow ETF
DGT
$614M
$5.13M 0.13%
34,060
+4,296
+14% +$610K
VEA icon
149
Vanguard FTSE Developed Markets ETF
VEA
$230B
$5.11M 0.13%
89,700
+7,109
+9% +$381K
GBTC icon
150
Grayscale Bitcoin Trust
GBTC
$9.73B
$5.09M 0.13%
59,964
-1,090
-2% -$84.8K

Similar funds

Bleakley Financial Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bleakley Financial Group held 591 positions worth $3.94B, up 26% from $3.12B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bleakley Financial Group deployed $523M of net new capital in Q2 2025, opening 86 new positions and adding to 351 existing holdings. Its largest new stake was Fidelity Total Bond ETF: 769,847 shares worth $35.2M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $15.3M trimmed.

  • Bleakley Financial Group's largest Q2 2025 buy was Fidelity Total Bond ETF: 769,847 shares worth $35.2M.
  • Bleakley Financial Group added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $61.4M increase.
  • Bleakley Financial Group's biggest Q2 2025 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $15.3M.
  • Bleakley Financial Group fully exited Pacer US Cash Cows 100 ETF in Q2 2025, selling an estimated $17.6M.
  • Bleakley Financial Group's ten largest holdings make up 29% of its $3.94B portfolio in Q2 2025.
  • Bleakley Financial Group opened 86 new positions and closed 21 in Q2 2025.
  • Bleakley Financial Group's portfolio value rose 26% quarter-over-quarter to $3.94B.

Based on Bleakley Financial Group's 13F filing for Q2 2025, filed 30 Jul 2025.